Novavax Inc (NASDAQ:NVAX)

6.26
Delayed Data
As of 2:41pm ET
 -0.29 / -4.43%
Today’s Change
4.01
Today|||52-Week Range
51.60
-82.99%
Year-to-Date

Today’s Trading

Previous close6.55
Today’s open6.56
Day’s range6.20 - 6.63
Volume347,565
Average volume (3 months)881,135
Market cap$156.9M
Data as of 2:41pm ET, 09/23/2019

Growth & Valuation

Earnings growth (last year)+20.69%
Earnings growth (this year)+45.10%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales19.84
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LCTXLineage Cell Therape...-0.01-0.93%
TLCTaiwan Liposome Co L...+0.15+2.90%
ALDXAldeyra Therapeutics...-0.04-0.59%
DYAIDyadic International...+0.27+4.40%
Data as of 2:54pm ET, 09/23/2019

Financials

Next reporting dateNovember 7, 2019
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$34.3M
Annual profit (last year)-$184.7M
Net profit margin-538.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
CFO, Treasurer, Chief Business Officer &
Senior VP
John J. Trizzino
Corporate headquarters
Gaithersburg, Maryland

Forecasts